Full Factorial Design, Optimization, In vitro and Ex vivo Studies of Ocular Timolol-Loaded Microsponges
- 36 Downloads
Timolol maleate (TMM) is a hydrophilic model drug. The aim of this study was to formulate TMM-loaded microsponges to sustain TMM release and improve its corneal permeability compared with TMM-aqueous solution.
The modified quasi-emulsion solvent diffusion technique (water/oil/oil) was used to prepare TMM-loaded microsponges. The impact of the polymer type (X1) and drug:polymer ratio (X2) were studied and optimized, using full factorial design. The production yield (PY) %, entrapment efficiency (EE) %, particles size (PS), and TMM released % after 6 h were selected as dependent variables. Depended on the desirability value by using the Design-Expert® software version 11, the optimized formulation was selected and subjected to further studies, such as scanning electron microscopy (SEM), porosity determination, powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), ex vivo permeation study, and corneal hydration level.
The optimized formulation composed of TMM: EC within the proportion 1:9 exhibited PY of 96.55 ± 4.01%; EE of 72.00 ± 6.08%; PS (d90) of 6283.33 ± 145.71 nm and released 42.12 ± 3.93% of TMM after 6 h. Particles appeared porous with spherical shape. Thermal analysis proved that the drug has been homogeneously dispersed in its amorphous state. The optimized formulation showed higher corneal permeability about 1.45-fold higher than TMM-aqueous solution in a period of 6 h.
The modified quasi-emulsion diffusion technique (water/oil/oil) is suitable for improving EE of hydrophilic drug (TMM) and the optimized TMM-loaded microsponge was succeeded to retard the release of TMM and improve its corneal permeability.
KeywordsMicrosponges Water/oil/oil Timolol Optimization In vitro release Ex vivo permeation study
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Mohite P, Khanage S, Harishchandre V, Shirsath Y. Recent advances in microsponges drug delivery system. J Crit Rev. 2016;3(1):9–16.Google Scholar
- 6.Joshi G, RajandeepKaur HK. Microsponges: a novel drug delivery system. Int Res J Pharm Biosci. 2016;3(1):01–11.Google Scholar
- 7.Junqueira MV, Bruschi ML. A review about the drug delivery from microsponges. AAPS PharmSciTech. 2018:1–11.Google Scholar
- 8.Aloorkar N, Kulkarni A, Ingale D, Patil R. Microsponges as innovative drug delivery systems. Int J Pharm Sci Nanotechnol. 2012;5:1597–606.Google Scholar
- 9.Aydogan E, Comoglu T, Pehlivanoglu B, Dogan M, Comoglu S, Dogan A, et al. Process and formulation variables of pregabalin microspheres prepared by w/o/o double emulsion solvent diffusion method and their clinical application by animal modeling studies. Drug Dev Ind Pharm. 2015;41(8):1311–20.PubMedCrossRefPubMedCentralGoogle Scholar